Diabetes affects approximately 450 million adults globally. If not effectively managed,
chronic hyperglycaemia causes tissue damage that can develop into fibrosis. Fibrosis leads …

Diabetes mellitus is a metabolic disease manifested by hyperglycemia. For patients with
type 1 and advanced type 2 diabetes mellitus, insulin therapy is essential. Subcutaneous …

Antidiabetic therapeutics, including insulin as well as glucagon-like peptide 1 (GLP-1) and
its analogs, are essential for people with diabetes to regulate their blood glucose levels …

This review aims at focusing on the use of microneedles (MNs) as an emerging novel drug
delivery carrier for an effective treatment in diabetic patients. There are many limitations in …

Microneedles have the clinical advantage of being able to deliver complex drugs across the
skin in a convenient and comfortable manner yet haven't successfully transitioned to medical …

Insulin medication is currently effective in the treatment of type I diabetes. Due to the poor
absorption or enzymatic degradation of insulin in the gastrointestinal tract and liver, the …

Diabetes, a metabolic disorder of glucose, is a serious chronic disease and an important
public health problem. Insulin is one of the hormones for modulating blood glucose level …

Microneedle (MN) delivery devices are more accepted by people than regular traditional
needle injections (eg vaccination) due to their simplicity and adaptability. Thus, patients of …

Treatment of insulin-dependent diabetes mellitus, also known as Type 1 diabetes mellitus,
requires delivery of exogenous insulin via injection or pump. An alternative to syringe-based …

Although subcutaneously implanted continuous glucose monitoring (CGM) devices have
been shown to support diabetes self-management, their uptake remains low due to a …